Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The 10 Most Heavily Shorted Bio-Pharma Stocks
TheStreet.com
Monday, February 24, 2014 - 11:15am
tags:
Spectrum Pharmaceuticals, Dendreon, Achillion, Ziopharm, Intrexon, Arena Pharmaceuticals, Idenix, Synta Pharmaceuticals, Sarepta Therapeutics, Myriad Genetics
ImmunoCellular: Is Approval Enough?
Seeking Alpha
Monday, February 24, 2014 - 11:12am
tags:
ImmunoCellular Therapeutics, ICT-107, DCVax®-L, Northwest Biotherapeutics, glioblastoma multiforme
2 Cell Therapy Companies That Could Thrive With Cardiovascular Disease Treatments
Seeking Alpha
Monday, February 24, 2014 - 11:11am
tags:
stem cells, cardiovascular disease, Athersys, NeoStem, AMR-001, MultiStem
3 Under-the-Radar Biotech Stocks You Need to Watch in 2014
Motley Fool
Monday, February 24, 2014 - 10:10am
tags:
Nektar, Omeros, Spectrum Pharmaceuticals
Bayer Set to Acquire Algeta in First Quarter
Marketwatch
Monday, February 24, 2014 - 10:07am
tags:
Bayer, Algeta, M&A
Ardelyx licenses NaP2b phosphate inhibitor program to Sanofi
Yahoo/Fly on the Wall
Monday, February 24, 2014 - 9:57am
tags:
Sanofi, Ardelyx, NaP2b phosphate inhibitor
Bristol-Myers Squibb Receives U.S. FDA Breakthrough Therapy Designation for All-Oral Daclatasvir Dual Investigational Regimen for Chronic Hepatitis C
Yahoo
Monday, February 24, 2014 - 9:55am
tags:
daclatasvir, breakthrough therapies, FDA, Bristol-Myers Squibb, hepatitis C
Attack On Lung Cancer: Eli Lilly Vs. Rivals
Seeking Alpha
Monday, February 24, 2014 - 9:53am
tags:
Eli Lilly, non-small cell lung cancer, Roche, ramucirumab, Sanofi
Here’s Why Novartis’ Japanese Unit Was Raided
Wall St Cheat Sheet
Monday, February 24, 2014 - 9:22am
tags:
Novartis, Japan, Diovan
Pfizer to again ship thyroid drug Levoxyl following recall, WSJ reports
Yahoo/Fly on the Wall
Monday, February 24, 2014 - 9:20am
tags:
Pfizer, hypothyroidism, Levoxyl
Ignyta: Now Public With A Targeted Oncology Pipeline Poised For Success
Seeking Alpha
Monday, February 24, 2014 - 9:19am
tags:
Ignyta, oncology, Clovis Oncology, Ariad Pharmaceuticals, Mirati Therapeutics, Tesaro, Puma Biotechnology
Lilly Agrees to Buy Animal Health Firm, Cuts Outlook
Marketwatch
Monday, February 24, 2014 - 9:00am
tags:
M&A, animal health, Eli Lilly, Elanco, Lohmann SE
McKinsey's View That Pharma Megamergers Work Is Short Sighted
Forbes
Monday, February 24, 2014 - 8:56am
tags:
M&A, R&D
Pfizer Vaccine Study Could Change Medicine (And Boost Stock)
Forbes
Monday, February 24, 2014 - 8:52am
tags:
Pfizer, vaccines, Prevnar 13, pneumonia
Amarin Loses Bid for Vascepa 5-Year Market Exclusivity
TheStreet.com
Monday, February 24, 2014 - 8:51am
tags:
Amarin, Vascepa
Is Buffett Abandoning Health-Care Stocks?
Motley Fool
Sunday, February 23, 2014 - 11:21am
tags:
Warren Buffett
Breaking Down Abstral Sales For Galena Biopharma
Seeking Alpha
Sunday, February 23, 2014 - 11:20am
tags:
Galena Biopharma, Abstral, cancer pain, pain management
China pharmaceutical industry sees steady growth
Shanghai Daily, China
Saturday, February 22, 2014 - 11:36am
tags:
China
Pharmaceutical giant Roche puts sprawling NJ campus on market
The Real Deal
Saturday, February 22, 2014 - 11:34am
tags:
Roche
Teva Completes Tender Offer for NuPathe Inc. Shares
Pharmiweb
Saturday, February 22, 2014 - 11:31am
tags:
Teva Pharmaceuticals, NuPathe

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.